ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 731093 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 731093; 2) Community: the network communities that were significantly associated with the response to NSC 731093; 3) Molecule: the relationships between components within communities and NSC 731093; 4) MDR: the compounds that were significantly associated with the NSC 731093.

NSC Compound Enrichment Correlation
NSC 722779 dabequine 0.0114553853234976 0.091527359
NSC 724771 Null 0.0114553853234976 0.26721371
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0114553853234976 0.28124454
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0114553853234976 0.38070498
NSC 732112 6-(O-ethyl-2?-diethylamino)-7-(p-methoxycinnamoyl)-3-methyl- benzofuran-2-carboxylic acid ethyl ester hydrochloride 0.0114553853234977 0.13078135
NSC 737318 6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline 0.0114553853234977 0.19008201
NSC 744178 Null 0.0114553853234977 0.33131793
NSC 754824 4-[4-(3-Methoxy-phenyl)-piperazin-1 -yl]-5H-pyrrolo[3,2-d]pyrimidine 0.0114553853234977 0.31573612
NSC 755417 Null 0.0114553853234977 0.27970763
NSC 86371 Quinolinium, 2-[2-(8-hydroxy-5-methyl-7-quinolyl)vinyl]-1,6-dimethyl- iodide 0.0114553853234977 0.30878341
Total:155  Current:62    [First] [Prev] [Next] [Last]